Organizations Filed Purposes:
THE MISSION OF GE2P2 GLOBAL FOUNDATION (FOUNDATION) IS TO ADVANCE ETHICAL AND SCIENTIFIC RIGOR IN RESEARCH AND EVIDENCE GENERATION ACROSS HUMAN RIGHTS, HUMANITARIAN RESPONSE, HEALTH, EDUCATION, HERITAGE STEWARDSHIP, AND DEVELOPMENT.
ADVANCING SCIENTIFIC RIGOR AND ETHICAL RESILIENCE IN RESEARCH AND EVIDENCE GENERATION
THE FOUNDATION OPERATES THROUGH A PORTFOLIO OF CENTERS AND PROGRAMS TO FOCUS THE WORK AND ENGAGES THE COMPETENCIES, EXPERIENCE, AND INSIGHTS OF A GLOBAL NETWORK OF ELECTED "FELLOWS" OF THE FOUNDATION. FELLOWS WILL INCLUDE ACADEMIC, AGENCY AND GOVERNMENT LEADERS, FIELD PRACTITIONERS, SCIENTISTS, RESEARCHERS, ETHICISTS, DOMAIN AND CULTURAL CONTEXT EXPERTS, SCHOLARS IN THE SOCIAL AND BIO SCIENCES AND THE HUMANITIES, KNOWLEDGE MANAGEMENT EXPERTS, AND MANY OTHERS. DURING 2019 THE FOLLOWING CENTERS WERE ACTIVE: (1) CENTER FOR VACCINE ETHICS AND POLICY (CVEP), (2) CENTER FOR DISASTER AND HUMANITARIAN ETHICS (CDHE), (3) CENTER FOR ETHICS AND POLICY ON ACCESS TO MEDICINES (CEPAM).CONTINUED ON SCHEUDLE O.(1) CDHE FOCUSES ON ETHICS, EVIDENCE GENERATION, AND POLICY INVOLVING HEALTH INTERVENTIONS, HUMAN RIGHTS, AND HUMANITARIAN RESPONSE TO THE FULL RANGE OF NATURAL AND MANMADE DISASTERS AND COMPLEX EMERGENCIES.(2) CVEP ENGAGES THE FULL LIFE-CYCLE OF ISSUES AROUND GLOBAL IMMUNIZATION AND VACCINES -- BUILDING AND REFINING ETHICAL FRAMEWORKS; ANALYZING AND COMMUNICATING ABOUT VACCINE EVIDENCE, ETHICS AND POLICY; INNOVATING NEW ANALYTICAL, VISUALIZATION AND DECISION APPROACHES AND CONVENING THE VACCINE COMMUNITY TO CONSIDER EVIDENCE, ETHICS AND PRACTICAL SOLUTIONS. CVEP ALSO OFFERS A KNOWLEDGE-SHARING SERVICE THROUGH PUBLICATION OF VACCINES AND GLOBAL HEALTH: THE WEEK IN REVIEW. THIS COMPREHENSIVE WEEKLY DIGEST AGGREGATES NEWS, EVENTS, ANNOUNCEMENTS, PEER-REVIEWED ARTICLES AND RESEARCH IN THE GLOBAL VACCINE ETHICS AND POLICY SPACE.(3) CEPAM CONDUCTS RESEARCH, CONVENES SYMPOSIA AND WORKSHOPS, PUBLISHES, AND DEVELOPS ETHICAL GUIDANCE AND POLICY CONCERNING FAIR, EQUITABLE AND EFFECTIVE ACCESS TO PHARMACEUTICAL PRODUCTS INCLUDING DRUGS, BIOLOGICS, VACCINES, ESSENTIAL MEDICINES AND MEDICAL DEVICES. FOCUS AREAS INCLUDE GENERAL BIOETHICAL ISSUES ASSOCIATED WITH RESEARCH, DISCOVERY, AND CLINICAL TRIALS FOR INVESTIGATIONAL MEDICINES; COMPASSIONATE USE/PRE-LICENSURE/EXPANDED ACCESS PROGRAMS, AND ACCESS TO VACCINES AND ESSENTIAL MEDICINES IN LOW RESOURCE SETTINGS AND HUMANITARIAN CONTEXTS GLOBALLY.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Nambusi Kyegombe | DIRECTOR THROUGH SEPT 2019 | 1 | $0 |
| Barbara K Redman Phd Mbe | DIRECTOR | 4 | $0 |
| Donal O'Mathuna Phd | DIRECTOR | 2 | $0 |
| Robert I Field Phd Mph Jd | DIRECTOR | 1 | $0 |
| Kristin A Feemster Md Mph Mshpr | DIRECTOR | 1 | $0 |
| Cynthia Cox-Roman | DIRECTOR | 1 | $0 |
| Jestina Doe Anderson Phd | DIRECTOR | 1 | $0 |
| Arthur L Caplan Phd | FOUNDING DIRECTOR | 1 | $0 |
| Joseph G Trainor Cpa | TREASURER | 1 | $0 |
| David R Curry Ms | PRESIDENT & CEO | 8 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042979349300329_public.xml